Patient Characteristics (n = 16)
| Characteristic | Data |
| Age (y) | 66 (59–75) |
| PSA initial (ng/mL) | 6.6 (5.9–88.1) |
| PSA nadir after SLND (ng/mL) | 0.4 (0.3–2.5) |
| PSA at time of PET (ng/mL) | 1.2 (0.6–2.8) |
| PSA doubling time (mo) | 1.8 (0–7.2) |
| PSA velocity (ng/mL/y) | 0.7 (0–2.2) |
| Interval from pre-SLND PET to SLND (mo) | 1.0 (1–2) |
| Interval from SLND to post-SLND PET (mo) | 3.5 (2–6) |
| ≥T3a | 12/16 (75%) |
| N1 | 6/13 (46%) |
| ISUP grade group ≥ 4 | 11/16 (69%) |
ISUP = International Society of Urologic Pathologists.
Qualitative data are expressed as frequency followed by percentages in parentheses; continuous data are expressed as median followed by IQR in parentheses.